Catalyst Wire Dossier Catalyst Wire Dossier

HCP1102

· Hanmi Pharmaceutical Company Limited
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for HCP1102, covering 2017-12-13 to 2020-03-27. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of HCP1102 Capsule in Patients With Perennial Allergic Rhinitis [Phase 3]

See pricing